NCT03001973 High Quality Evidence of Chinese Lupus Nephritis (HELP)
| NCT ID | NCT03001973 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sun Yat-sen University |
| Condition | Lupus Nephritis |
| Study Type | OBSERVATIONAL |
| Enrollment | 5,000 participants |
| Start Date | 2013-11 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 5,000 participants in total. It began in 2013-11 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The investigators are registering LN patients at recruited hospitals and developing a LN database in China. Patients will be follow-up every year, and both baseline and follow-up information will be entered into the registration system.
Eligibility Criteria
Inclusion Criteria: * Patients who diagnosis as lupus nephritis Exclusion Criteria: * No
Contact & Investigator
Xueqing Yu, M.D. & Ph.D
✉ yuxq@mail.sysu.edu.cnFrequently Asked Questions
Who can join the NCT03001973 clinical trial?
This trial is open to participants of all sexes, aged 14 Years or older, studying Lupus Nephritis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03001973 currently recruiting?
Yes, NCT03001973 is actively recruiting participants. Contact the research team at yuxq@mail.sysu.edu.cn for enrollment information.
Where is the NCT03001973 trial being conducted?
This trial is being conducted at Guangzhou, China.
Who is sponsoring the NCT03001973 clinical trial?
NCT03001973 is sponsored by Sun Yat-sen University. The trial plans to enroll 5,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.